Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Same-day Discharge Following PCI: A Meta-analysis of RCTs
Author(s): Ngoc Huy Nguyen , Thanh Ngoc Le , Hoai Thi Thu Nguyen , et al Added: 4 months ago

Intervention
TCT 2025: 10-Year Mortality in NOBLE: PCI vs CABG for Left Main Disease
Author(s): Evald Høj Christiansen Added: 2 weeks ago
TCT 2025 - 10-year findings from NOBLE showed no safety concerns for percutaneous coronary intervention (PCI) compared to coronary artery bypass surgery (CABG) for the treatment of left main coronary artery (LMCA) disease.Dr Evald Høj Christiansen (Aarhus University Hospital, Aarhus, DK) joins us to share the 10-year mortality findings from the NOBLE trial, investigating PCI vs CABG in LMCA… View more

Intervention

Prevention & Chronic Conditions
Sex Difference in Relative Survival Following PCI
Author(s): Jin-Ho Choi , Jung-Min Choi , Ki-Hong Choi , et al Added: 1 year ago

Demographic

Intervention
EuroPCR 24: Influence of Pathophysiological Patterns of CAD on PCI
Author(s): Carlos Collet Added: 1 year ago
EuroPCR 24 - We are joined onsite by Dr Carlos Collet (OLV Hospital Aalst, BE) to discuss the findings from a study analysing the influences of the pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI.The study aimed to assess the capacity of pullback pressure gradient (PPG) in predicting post-PCI fractional flow ratio (FFR), as well as the impact of PPG on… View more

Intervention
Zero-Contrast PCI Using HD IVUS and Physiological Guidance
Author(s): Joost Daemen , Allen Jeremias , Ziad A Ali Added: 2 years ago
Join us for an informative video that explores the innovative approach of performing zero-contrast percutaneous coronary intervention (PCI) using advanced medical technologies and best practices. In recent years, contrast supply shortages and the need for improved patient outcomes have presented significant challenges in care delivery. In this video, our esteemed faculty will demonstrate the… View more

Imaging & Diagnostics

Intervention
ACC.24: FFR or Culprit-Only PCI in STEMI
Author(s): Felix Böhm Added: 1 year ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions… View more

Intervention

MI/ACS
Coronary Physiology and DCBs: The Modern Approach for CTO-PCI
Author(s): Roberto Garbo , , , et al Start date: Jun 03, 2024
Join us for a transformative broadcast, chaired by Dr Tomáš Kovárník (Charles University, Prague, CZ), showcasing the latest advancements in CTO PCI procedures with state-of-the-art technology.Investigate the possibility of shortening stent lengths with precision physiology guidance, featuring Dr Mohamed Ayoub's (University Heart Center NRW, Bad Oeynhausen, DE) presentationExplore the combination… View more

Imaging & Diagnostics

Intervention
TCT 2025: SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
Author(s): Christian Spaulding Added: 2 weeks ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional… View more

Intervention
IVUS Guided Bifurcation PCI with HDi IVUS
Author(s): Joost Daemen Added: 1 year ago
Clinical data shows that routine use of intravascular imaging improves clinical outcomes of patients undergoing PCI. It delivers critical anatomical information pre-and post-stenting. Thereby, HD-IVUS enables “high-precision” interventional therapy. especially for complex PCI procedural guidance. View more

Imaging & Diagnostics

Intervention
AHA 25: TUXEDO-2: Ticagrelor vs Prasugrel in Diabetic PCI
Author(s): Sripal Bangalore , Harriette Van Spall Added: 5 days ago
AHA Scientific Sessions 2025 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) was joined by the TUXEDO-2 Principal Investigator, Dr Sripal Bangalore to present the findings of this late-breaking randomized trial comparing ticagrelor versus prasugrel in patients with diabetes mellitus and multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI)… View more

Anticoagulation

Intervention